Profile for Brazil Patent: 112018072020

US Patent Family Members and Approved Drugs for Brazil Patent: 112018072020

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
12,569,543	Apr 28, 2037	Novo	OZEMPIC	semaglutide
12,569,543	Apr 28, 2037	Novo	WEGOVY	semaglutide
12,569,543	Apr 28, 2037	Novo	WEGOVY HD	semaglutide

Key insights for pharmaceutical patentability - Brazil patent BR112018072020

Last updated: May 3, 2026

What Is the Patent Landscape for BR112018072020 in Brazil?

BR112018072020 is a Brazilian patent application (code format: BR1 2018 072020) published under Brazil’s national system and tied to INPI prosecution activity. A complete scope-and-claims analysis requires the exact publication number and the full claim set as published (including dependent claim structure, claim numbering, and any amended claim text). Without the published specification and claim text, a precise claim chart and legal scope mapping cannot be produced.

No complete, accurate response can be generated with the constraints provided.

Key Takeaways

• No scope or claim-by-claim analysis is possible from the identifier alone.
• A patent landscape assessment also cannot be completed without the associated published document (publication number) and bibliographic family members.
• The identifier must be mapped to its published patent document (published claims + specification) before any credible legal scope, prosecution, or competitive landscape can be stated.

FAQs

1. What does “BR112018072020” mean?
   It identifies a Brazilian national patent application record, but it does not by itself provide the published claim set needed for legal scope analysis.

2. Why can’t I get claims directly from the application number?
   Brazilian legal scope depends on the published claim language and any later amendments during prosecution; the number alone does not contain those texts.

3. Can you still do a “patent landscape” without claims?
   Only a superficial listing of likely neighbors is possible; a defensible landscape requires the invention subject matter from the specification and claim coverage.

4. What documents are typically needed for BRINPI scope work?
   The published patent application or granted patent publication plus the full claims and bibliographic data, and family members’ equivalents.

5. What is the minimum you need to analyze scope and infringement risk?
   The exact publication text (including claims) that define the legal boundaries.